Eli Lilly’s COVID drug bebtelovimab not currently authorized in U.S., says FDA

(Reuters) – The U.S. Food and Drug Administration said on Wednesday Eli Lilly (NYSE:) and Co’s COVID-19 drug bebtelovimab is not currently authorized for emergency use in the country as it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.

Source link